EZP 3P EZP CG Blend 12.5mg 2.5mg Research Grade Compound retatrutide and cagrilintide 15mg 5mg Retatrutide Research Peptide Triple Agonist PurePeptix Australia The most intensive medical obesity therapy in the pipeline is retatrutide. Retatrutide is the "triple G," a glucose dependent insulinotropic polypeptide (GIP), glucagon like peptide 1 (GLP 1), and glucagon receptor agonist. It has demonstrated robust blood Retatrutide (Reta GLP 3) 10mg Triple Agonist Research Peptide GLP 3 RT Peptide US Delivery Titan Research